Immunopharmacological activities and clinical development of muramyl peptides with particular emphasis on murabutide-Reference-Cited by-同舟云学术

Immunopharmacological activities and clinical development of muramyl peptides with particular emphasis on murabutide

Published:1995-02 Issue:2 Volume:17 Page:117-131
ISSN:0192-0561
Container-title:International Journal of Immunopharmacology
language:en
Short-container-title:International Journal of Immunopharmacology

Author:

Bahr George M.,Darcissac Edith,Bevec Dorian,Dukor Peter,Chedid Louis

Publisher

Elsevier BV

Subject

Pharmacology,Immunology

Reference69 articles.

1. Liposomal muramyl tripeptide up-regulates interleukin-1 alpha, interleukin-1 beta, tumor necrosis factor-alpha, interleukin-6 and interleukin-8 gene expression in human monocytes;Asano;J. Pharmac. exp. Ther.,1994

2. Control of IgE responses II. Isotype specific suppression of peak hapten specific IgE antibody forming cell responses in BPO-KLH sensitized mice after oral administration of muramyldipeptide or murabutide;Auci;Immunopharmacology,1993

3. Adjuvants: current status, clinical perspectives and future prospects;Audibert;Immun. Today,1993

4. Review: inducer of cytokines in vivo: overview of field and Romurtide experience;Azuma;Int. J. Immunopharmac.,1992

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anti-neoplastic and immunomodulatory potency of co-treatment based on bovine lactoferrin and/or muramyl dipeptide in tumor-bearing mice;Toxicology Research;2020-04

2. Harnessing the untapped potential of nucleotide‐binding oligomerization domain ligands for cancer immunotherapy;Medicinal Research Reviews;2018-12-13

3. A cell-based test system for the assessment of pharmacokinetics of NOD1 and NOD2 receptor agonists;International Immunopharmacology;2018-10

4. NOD1 and NOD2: Molecular targets in prevention and treatment of infectious diseases;International Immunopharmacology;2018-01

5. Differential regulation of surface receptor expression, proliferation, and apoptosis in HaCaT cells stimulated with interferon-γ, interleukin-4, tumor necrosis factor-α, or muramyl dipeptide;International Journal of Immunopathology and Pharmacology;2017-04-28